Actual Medicinal Product (AMP) - Glyxambi 25mg/5mg tablets (Boehringer Ingelheim Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Glyxambi 25mg/5mg tablets | Start Date 01-06-2019 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| Code | Start Date | End Date |
|---|---|---|
| 37225511000001102 | 01-06-2019 |
Parent Products
-
VTMEmpagliflozin + Linagliptin
-
VMPEmpagliflozin 25mg / Linagliptin 5mg tablets
-
AMP(Current) Glyxambi 25mg/5mg tablets (Boe...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 28 tablet | 5588 |